Rank #1895DYN

Dyne Therapeutics, Inc.

$15.25

-0.85% (Daily)

Market Cap

$2.51B

Revenue

$N/A

Rank by MCap

#1895

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. John G. Cox M.B.A.

Headquarters

Waltham, MA

Employees

240

About Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying the...